Stem Cell Therapy for Osteoarthritis - A Pipeline Analysis Report
- Published: Oct 2017
- Pages: 93
- SKU: IRTNTR15693
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
This pipeline analysis report identifies Mesoblast, Regeneus, U.S. Stem Cell, Anterogen, Asterias Biotherapeutics as some of the key companies that are actively involved in the development of gene therapy for osteoarthritis patients. The report also presents a comprehensive analysis of the therapeutic assessment by therapy (monotherapy and combination therapy), by ROA (intra-articular, implant, and unspecified), and by stage and ROA (phase III, phase I/II, phase I and IND, and pre-clinical). This pipeline analysis report also provides an analysis of stem cell therapy for osteoarthritis based on indications such as osteoarthritis (unspecified), knee osteoarthritis, shoulder osteoarthritis, and hip osteoarthritis.
Overview of the pipeline analysis report on stem cell therapy for osteoarthritis
Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. With the increasing awareness of osteoarthritis, the rise in diagnosis rates, the growing older population, and the increasing cases of obesity, the osteoarthritis market will witness considerable growth in the coming years. According to Technavio’s pipeline analysis report, most of the molecules under investigation are currenty in the early stages of development.
Our comparative analysis on the molecules in the pipeline for the stem cell therapy for osteoarthritis has identified that most of these molocules are in the pre-clinical, phase I, and phase II stages. GID Group’s GID SVF is in the phase III (pivotal) stage and the drug is based on GID technology. It is a monotherapy drug and can be administered through a single-use disposable device.
Key companies
This pipeline analysis report has identified fourteen companies that are actively involved in the development of stem cell therapy for osteoarthritis. Based on the companies’ revenue, this report has segregated the players into Tier 1, Tier 2, and Tier 3 companies. One of the major Tier 1 companies Mesoblast, is a leading player in the biotechnology industry and registered a revenue of almost USD 43 million in 2016.
The Tier 1 companies covered in the are –
- Mesoblast
- Regeneus
- U.S. Stem Cell
- Anterogen
- Asterias Biotherapeutics
Therapeutic assessment of stem cell therapy osteoarthritis pipeline molecules by therapy
- Monotherapy
- Combination therapy
Monotherapy drugs are used to treat a particular disease. Our analysts have identified that all the stem cell therapy osteoarthritis drugs that are currently in the pipeline are being developed as a monotherapy agent.
Analysis of the stem cell therapy osteoarthritis pipeline molecules by indication
- Osteoarthritis (unspecified)
- Knee osteoarthritis
- Shoulder osteoarthritis
- Hip osteoarthritis
Most of the companies currently involved in the stem cell therapy for osteoarthritis focus on the knee osteoarthritis segment. VivaTech International is the only company that si focusing on the shoulder, hip, and knee osteoarthritis.
Key questions answered in the report include
- What are the different stages of the pipeline molecules in investigation?
- What are the molecules in the various development stages in the stem cell therapy for osteoarthritis pipeline?
- Who are the key companies currently involved in the development of stem cell therapy for osteoarthritis?
- What are the inactive molecules in the stem cell therapy for osteoarthritis?
- What are the major regulatory authorities approving drugs in various regions?
Technavio also offers customization on reports based on specific client requirement.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
PART 05: MAJOR REGULATORY AUTHORITIES
- US
- Europe
- China
PART 06: PIPELINE LANDSCAPE
PART 07: COMPARATIVE ANALYSIS
- Discovery stage molecules
- Pre-clinical stage molecules
- Inactive and discontinued molecules
PART 08: INDICATION ANALYSIS
PART 09: THERAPEUTIC ASSESSMENT (THERAPY BASED)
PART 10: THERAPEUTIC ASSESSMENT (ROA BASED)
PART 11: THERAPEUTIC ASSESSMENT BY TARGET
PART 12: KEY COMPANIES
- Active companies: Category and parameters
PART 13: APPENDIX
- List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
